Investigating inducible muscle overactivity in acquired brain injury and the impact of Botulinum Toxin A.

Author(s):  
Ian J. Baguley ◽  
Hannah L. Barden ◽  
Karen Byth
Brain Injury ◽  
2012 ◽  
Vol 26 (7-8) ◽  
pp. 979-983 ◽  
Author(s):  
Alessandro Clemenzi ◽  
Rita Formisano ◽  
Maria Matteis ◽  
Luciano Gallinacci ◽  
Giulio Cochi ◽  
...  

2009 ◽  
Vol 12 (3) ◽  
pp. 128-138 ◽  
Author(s):  
Emilie Guettard ◽  
Emmanuel Roze ◽  
Genevieve Abada ◽  
Catherine Lemesle ◽  
Marie Vidailhet ◽  
...  

2019 ◽  
Vol 112 (3) ◽  
pp. e246
Author(s):  
Youn-Jung Kang ◽  
Sooyeon Kim ◽  
Siwon Lee ◽  
Hwang Kwon ◽  
Jung-Jae Ko ◽  
...  

2006 ◽  
Vol 2 (1) ◽  
Author(s):  
Mohammed El Maaytah ◽  
Waseem Jerjes ◽  
Tahwinder Upile ◽  
Brian Swinson ◽  
Colin Hopper ◽  
...  

2021 ◽  
Vol 1 (4) ◽  
Author(s):  
Yan Li ◽  
Aleksandra Grobelna

No relevant literature was identified regarding the clinical effectiveness or cost-effectiveness of onabotulinum toxin A (Botox) for reducing spasticity in patients with traumatic or non-traumatic–acquired brain injury. Authors of 1 evidence-based guideline recommend the use of botulinum toxin (subtype and formulation not specified) for the treatment of spasticity associated with traumatic brain injury.


Brain Injury ◽  
2004 ◽  
Vol 18 (1) ◽  
pp. 57-63 ◽  
Author(s):  
Jimy Fock ◽  
Mary P. Galea ◽  
Barry C. Stillman ◽  
Barry Rawicki ◽  
Malcolm Clark

Sign in / Sign up

Export Citation Format

Share Document